Nanoparticle-mediated delivery of irbesartan reduces myocardial ischemia/reperfusion injury in mice via pparγ -dependent mechanisms

Nanoparticle-Mediated Delivery of Irbesartan Reduces Myocardial ,VFKHPLD5HSHUIXVLRQ,QMXU\LQ0LFHYLD33$5-Dependent Yasuhiro Nakano, Tetsuya Matoba, Gentaro Ikeda, Kaku Nakano, Kensuke Egashira Irbesartan-NP reduced infarct size via PPAR pathway. Therapeutic effect of early myocardial reperfusion in acute myocardial infarction is limited by ischemia-reperfusion (IR) injury [1]. Novel drug delivery system might overcome insufficient therapeutic efficacy of current medicines for IR injury [2]. Here we hypothesized that nanoparticle-mediated delivery of irbesartan, an angiotensin receptor blocker that possesses a partial agonistic effect on peroxisome reperfusion ameliorates IR injury [3]- [5]. In a murine model of a 30-min myocardial IR injury, we examined cellular distribution of poly-lactic-co-glycolic acid (PLGA) nanoparticle containing fluorescein isothiocyanate (FITC-NP) or FITC solution intravenously administered 5 Figure 2. The role of AT1 receptor in infarct size after I/R. mins before reperfusion. Significant FITC fluorescence was detected in IR myocardium after the treatment with FITC-NP but not FITC solution. Flow cytometry (FCM) revealed FITC-NP uptake by monocytes and neutrophils that were recruited into the IR heart. Intravenous treatment with irbesartan-containing nanoparticle (Irb-NP, 3.0 mg/kg irbesartan) reduced infarct size 24 hours after reperfusion, which was caQFHOHG E\ WKH SUHWUHDWPHQW ZLWK 33$5 antagonist GW9662 (Fig 1). Importantly, Irb-NP was effective to reduce IR injury even in AT1-deficient mice. In losartan-containing nanoparticle (10 mg/kg losartan), or irbesartan solution (3.0 mg/kg) was ineffective (Fig 2). Irb-13 VLJQLILFDQWO\ LQFUHDVHG 33$5 DFWLYLW\ DQG decreased NF-%DFWLYLW\LQWKHQXFOHDUH[WUDFWIURP WKH ,5 myocardial tissue, which were canceled by the pretreatment with GW9662. FCM 12 hours after reperfusion revealed that Irb-NP reduced neutrophils and Ly6Chigh inflammatory [1] Derek M. Yellon, Derek J. Hausenloy. Myocardial Reperfusion Injury. N Engl J Med. 2007;357:1121-1136. [2] Abhiram Prasad, Gregg W. Stone, David R. Holmes, Bernard Gersh. NP-mediated delivery of irbesartan into leukocytes and IR Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection. myocardium reduced myocardial IR injury via [3] Florian Leuschner, Filip K. Swirski, Ralph Weissleder, Matthias Nahrendorf. Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction. Circulation Research. 2010;107:1364-1373 [4] Tian-li Yue, Robin E. Buckingham and Eliot H. Ohlstein. In Vivo Myocardial Protection From Ischemia/Repefsuion Injury by the Peroxisome Proliferator-Activated Receptor- Agonist Rosiglitazone. All authors are with the Department of Cardiovascular medicine Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, [5] Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing Higashi-ku, Fukuoka, Japan (corresponding author to provide phone: (+81)92-642-5359; fax: (+81)92-642-5374; e-mail:


Microsoft word - drugs found guilty of causing painr04-03-10pdf3

The Cure for Chronic Pain How You Can Help Yourself Heal Series Drugs Found Guilty of Causing Pain Nancy S. Moore, PhD, RN March, 2011 Copyright© 2011 By Natural-Healing-Health All rights reserved. Unauthorized reproduction of this report or its contents is illegal, except as brief quotations in reviews or articles. This report is for informational purposes only. Read

20 ème Course St Just St Rambert - Chambles dimanche 26 décembre 2010 - St Just St Rambert Résultats individuels : classement arrivee Logica Cross et Route — © 2002 Fédération Française d’AthlétismeLogica Cross et Route — © 2002 Fédération Française d’AthlétismeLogica Cross et Route — © 2002 Fédération Française d’Athlétisme 1h00'04'' 1h00'07'' 1

Copyright © 2010-2018 Pharmacy Drugs Pdf